Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

Synaptic dysfunction in depression: potential therapeutic targets.

Duman RS, Aghajanian GK.

Science. 2012 Oct 5;338(6103):68-72. doi: 10.1126/science.1222939. Review.

PMID:
23042884
[PubMed - indexed for MEDLINE]
2.

A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists.

Duman RS, Li N.

Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2475-84. doi: 10.1098/rstb.2011.0357. Review.

PMID:
22826346
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review.

Tang SW, Helmeste D, Leonard B.

World J Biol Psychiatry. 2012 Sep;13(6):402-12. doi: 10.3109/15622975.2011.639800. Epub 2011 Dec 19. Review.

PMID:
22175526
[PubMed - indexed for MEDLINE]
4.

Signaling pathways underlying the rapid antidepressant actions of ketamine.

Duman RS, Li N, Liu RJ, Duric V, Aghajanian G.

Neuropharmacology. 2012 Jan;62(1):35-41. doi: 10.1016/j.neuropharm.2011.08.044. Epub 2011 Sep 2. Review.

PMID:
21907221
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections.

Duman RS.

Dialogues Clin Neurosci. 2014 Mar;16(1):11-27. Review.

PMID:
24733968
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, A Gray N, Zarate CA Jr, Charney DS.

Biol Psychiatry. 2003 Apr 15;53(8):707-42. Review.

PMID:
12706957
[PubMed - indexed for MEDLINE]
7.

Pathophysiology of depression: the concept of synaptic plasticity.

Duman RS.

Eur Psychiatry. 2002 Jul;17 Suppl 3:306-10. Review.

PMID:
15177086
[PubMed - indexed for MEDLINE]
8.

Novel insights into depression and antidepressants: a synergy between synaptogenesis and neurogenesis?

Bambico FR, Belzung C.

Curr Top Behav Neurosci. 2013;15:243-91. doi: 10.1007/7854_2012_234. Review.

PMID:
23271325
[PubMed - indexed for MEDLINE]
9.

Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections.

Duman RS.

Depress Anxiety. 2014 Apr;31(4):291-6. doi: 10.1002/da.22227. Epub 2014 Mar 10. Review.

PMID:
24616149
[PubMed - indexed for MEDLINE]
10.

Talking to the synapse: how antidepressants can target glial cells to reshape brain circuits.

Di Benedetto B, Rupprecht R, Czéh B.

Curr Drug Targets. 2013 Oct;14(11):1329-35. Review.

PMID:
23517669
[PubMed - indexed for MEDLINE]
11.

Synaptic mechanisms underlying rapid antidepressant action of ketamine.

Kavalali ET, Monteggia LM.

Am J Psychiatry. 2012 Nov;169(11):1150-6. Review.

PMID:
23534055
[PubMed - indexed for MEDLINE]
12.

Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants.

Dwyer JM, Duman RS.

Biol Psychiatry. 2013 Jun 15;73(12):1189-98. doi: 10.1016/j.biopsych.2012.11.011. Epub 2013 Jan 4. Review.

PMID:
23295207
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment.

Banasr M, Duman RS.

CNS Neurol Disord Drug Targets. 2007 Oct;6(5):311-20. Review.

PMID:
18045159
[PubMed - indexed for MEDLINE]
14.

Modulation of synaptic plasticity by stress and antidepressants.

Popoli M, Gennarelli M, Racagni G.

Bipolar Disord. 2002 Jun;4(3):166-82. Review.

PMID:
12180272
[PubMed - indexed for MEDLINE]
15.

Antistress properties of antidepressant drugs and their clinical implications.

Calabrese F, Molteni R, Riva MA.

Pharmacol Ther. 2011 Oct;132(1):39-56. doi: 10.1016/j.pharmthera.2011.05.007. Epub 2011 May 27. Review.

PMID:
21640755
[PubMed - indexed for MEDLINE]
16.

The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior.

Schmidt HD, Duman RS.

Behav Pharmacol. 2007 Sep;18(5-6):391-418. Review.

PMID:
17762509
[PubMed - indexed for MEDLINE]
17.

Regulation of neurotrophic factors and energy metabolism by antidepressants in astrocytes.

Martin JL, Magistretti PJ, Allaman I.

Curr Drug Targets. 2013 Oct;14(11):1308-21. Review.

PMID:
23469874
[PubMed - indexed for MEDLINE]
18.

Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties.

Zunszain PA, Horowitz MA, Cattaneo A, Lupi MM, Pariante CM.

Mol Psychiatry. 2013 Dec;18(12):1236-41. doi: 10.1038/mp.2013.87. Epub 2013 Jul 23. Review.

PMID:
23877835
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Astrocytes and gliotransmitters: new players in the treatment of major depression?

Etiévant A, Lambás-Señas L, Scarna H, Lucas G, Haddjeri N.

Curr Drug Targets. 2013 Oct;14(11):1295-307. Review.

PMID:
24010966
[PubMed - indexed for MEDLINE]
20.

["Atypical" antidepressive mechanisms: glutamatergic modulation and neuroplasticity in case of tianeptine].

András S.

Neuropsychopharmacol Hung. 2008 Dec;10(5):305-13. Review. Hungarian.

PMID:
19419016
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk